BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33680526)

  • 1. A Case of Low-Grade Oncocytic Tumor/Chromophobe Renal Cell Carcinoma (Oncocytic Variant) of the Kidney.
    Ishikawa N; Kimura N; Yoshida T; Yoshimura I; Nakahara K; Tsuzuki T; Tokunaga O
    Case Rep Pathol; 2021; 2021():6684777. PubMed ID: 33680526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.
    Alghamdi M; Chen JF; Jungbluth A; Koutzaki S; Palmer MB; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Tickoo SK; Reuter VE; Chen YB
    Mod Pathol; 2024 May; 37(5):100467. PubMed ID: 38460672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
    Almutairi F; Xu B
    Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
    Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of vimentin, CD117, cytokeratin-7 and caveolin-1 in differentiation between clear cell renal cell carcinoma, chromophobe renal cell carcinoma and oncocytoma.
    El-Shorbagy SH; Alshenawy HA
    J Microsc Ultrastruct; 2017; 5(2):90-96. PubMed ID: 30023241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we need an updated classification of oncocytic renal tumors? : Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities.
    Hes O; Trpkov K
    Mod Pathol; 2022 Sep; 35(9):1140-1150. PubMed ID: 35273336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
    Lüders C; Kristiansen G
    Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algorithm-Based Approach to the Histological Routine Diagnosis of Renal Oncocytic Tumors in Core Biopsy Specimens.
    Manini C; Imaz I; de Larrinoa AF; López JI
    Curr Urol Rep; 2022 Nov; 23(11):327-333. PubMed ID: 36169870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics.
    Kravtsov O; Gupta S; Cheville JC; Sukov WR; Rowsey R; Herrera-Hernandez LP; Lohse CM; Knudson R; Leibovich BC; Jimenez RE
    Hum Pathol; 2021 Aug; 114():9-18. PubMed ID: 33961838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Grade Oncocytic Tumor: Report of Two Cases of An Emerging Entity in the Spectrum of Oncocytic Renal Neoplasms.
    Sharma D; Pai T; Prakash G; Desai S; Menon S
    Turk Patoloji Derg; 2022; 38(2):162-166. PubMed ID: 34514579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China.
    Guo Q; Liu N; Wang F; Guo Y; Yang B; Cao Z; Wang Y; Wang Y; Zhang W; Huang Q; Zhao W; Liu C; Qu T; Li L; Cao L; Ren D; Meng B; Qi L; Wang C; Cao W
    Virchows Arch; 2021 Mar; 478(3):449-458. PubMed ID: 32918598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
    Lobo J; Ohashi R; Amin MB; Berney DM; Compérat EM; Cree IA; Gill AJ; Hartmann A; Menon S; Netto GJ; Raspollini MR; Rubin MA; Tan PH; Tickoo SK; Tsuzuki T; Turajlic S; Zhou M; Srigley JR; Moch H
    Histopathology; 2022 Oct; 81(4):426-438. PubMed ID: 35596618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological features of hybrid oncocytic/chromophobe renal cell tumor].
    Wang Y; Chong DC; Xin FJ; He B; Liu XL; Li YJ; Zhang W; Jiang YX
    Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):97-102. PubMed ID: 33535302
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.
    Chen T; Peng Y; Lei T; Wu C; Wang H; Shi Y
    Pathol Oncol Res; 2023; 29():1610852. PubMed ID: 36816543
    [No Abstract]   [Full Text] [Related]  

  • 17. The diagnostic value of immunohistochemistry in the typing of renal tumors with eosinophylic cytoplasma.
    Kucuk S; Akpolat N
    Bratisl Lek Listy; 2020; 121(9):663-669. PubMed ID: 32990015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1.
    Morini A; Drossart T; Timsit MO; Sibony M; Vasiliu V; Gimenez-Roqueplo AP; Favier J; Badoual C; Mejean A; Burnichon N; Verkarre V
    Mod Pathol; 2022 Mar; 35(3):352-360. PubMed ID: 34531523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade oncocytic tumor (LOT) - a new renal entity ready for a prime time: An updated review.
    Mansoor M; Siadat F; Trpkov K
    Histol Histopathol; 2022 May; 37(5):405-413. PubMed ID: 35156688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of primary renal oncocytic tumor: Chromophobe renal cell carcinoma or oncocytoma?
    Matsui K; Uchida K; Kanai M; Asakawa K; Usui M; Murata T
    IJU Case Rep; 2023 Jan; 6(1):18-21. PubMed ID: 36605678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.